Literature DB >> 804565

Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials.

D L Fine, J C Landon, R J Pienta, M T Kubicek, M G Valerio, W F Loeb, H C Chopra.   

Abstract

Rhesus monkeys neonatally inoculated with Mason-Pfizer monkey virus (M-PMV) and virus-infected cells frequently developed viral and/or bacterial pneumonia and enteritis. Three characteristic hematologic patterns occurred among the inoculated animals and correlated well with the probability of survival. Postmortem examination of the animals revealed lymphadenopathy and thymic atrophy. M-PMV was present in lymph nodes, blood, brain, spleen, thymus, kidneys, and bone marrow. The disease induced in some animals had characteristics suggestive of a slow-virus-induced autoimmune response.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 804565

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


  22 in total

1.  Variable sensitivity to substitutions in the N-terminal heptad repeat of Mason-Pfizer monkey virus transmembrane protein.

Authors:  Chisu Song; Eric Hunter
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).

Authors:  B A Brody; E Hunter; J D Kluge; R Lasarow; M Gardner; P A Marx
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses.

Authors:  G P Harrison; E Hunter; A M Lever
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Experimental infection of rhesus monkeys with type D retrovirus.

Authors:  N L Letvin; M D Daniel; P K Sehgal; L V Chalifoux; N W King; R D Hunt; W R Aldrich; K Holley; D K Schmidt; R C Desrosiers
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Equine infectious anemia virus: evidence favoring classification as a retravirus.

Authors:  H P Charman; S Bladen; R V Gilden; L Coggins
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

8.  Subcutaneous fibromatosis associated with an acquired immune deficiency syndrome in pig-tailed macaques.

Authors:  C C Tsai; T F Warner; H Uno; W E Giddens; H D Ochs
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

9.  Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer monkey virus versus activity of human cell line derived virus PMFV.

Authors:  J Denner; L Indzhiia; V Wunderlich; G Sydow; D Bierwolf; B A Lapin
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis.

Authors:  C Strambio-de-Castillia; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.